Moreover, TGF-β–induced PI3K/Akt activation promotes the expression of stemness markers like ALDH1 and CD44^high/CD24^low, enabling tumor-initiating capacity and resistance to chemotherapy (139). The gene discussed is TGFB1; the disease is neoplasm.